| CXSS1900019 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(15) | New Drug Application | 2019-04-16 | 通化东宝药业股份有限公司 | Tonghua Dongbao Pharmaceutical Co Ltd | Certificate Issued | 2021-10-25 | view |
| CXSS1900018 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(15) | New Drug Application | 2019-04-16 | 通化东宝药业股份有限公司 | Tonghua Dongbao Pharmaceutical Co Ltd | Certificate Issued | 2021-10-25 | view |
| CXSS1900038 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(15) | New Drug Application | 2019-11-05 | 浙江海正药业股份有限公司 | Zhejiang Hisun Pharmaceutical Co Ltd | Certificate Issued | 2021-09-16 | view |
| CXSS1700030 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2018-01-18 | 珠海联邦制药股份有限公司 | Zhuhai United Laboratories Co Ltd | Certificate Issued | 2021-07-16 | view |
| CXSS1700029 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(15) | New Drug Application | 2018-01-18 | 珠海联邦制药股份有限公司 | Zhuhai United Laboratories Co Ltd | Certificate Issued | 2021-07-16 | view |
| CXSS1700028 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(15) | New Drug Application | 2018-01-18 | 珠海联邦制药股份有限公司 | Zhuhai United Laboratories Co Ltd | Certificate Issued | 2021-07-16 | view |
| CXSS1700031 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2018-01-18 | 珠海联邦制药股份有限公司 | Zhuhai United Laboratories Co Ltd | Certificate Issued | 2021-07-16 | view |
| CYSB2000140 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2020-06-09 | 诺和诺德（中国）制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2021-07-13 | view |
| JTS2100028 | 门冬胰岛素二级标准品 | insulin aspart | Active ingredient | Biological Products | Disposable Import Drug Application | 2021-04-14 | Novo Nordisk A/S | Novo Nordisk A/S | In Review | 2021-04-06 | view |
| CXSS2100025 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.3) | New Drug Application | 2021-02-26 | 宜昌东阳光长江药业股份有限公司 | Yichang HEC Changjiang Pharmaceutical Co Ltd | In Review | 2021-02-25 | view |
| CXSS2100019 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | New Drug Application | 2021-02-11 | 宜昌东阳光长江药业股份有限公司 | Yichang HEC Changjiang Pharmaceutical Co Ltd | In Review | 2021-02-10 | view |
| JTS2100007 | 门冬胰岛素二级标准品 | insulin aspart | Active ingredient | Biological Products | Disposable Import Drug Application | 2021-01-25 | Novo Nordisk A/S | Novo Nordisk A/S | Certificate Issued | 2021-02-10 | view |
| JTS2000059 | 门冬胰岛素二级标准品 | insulin aspart | Active ingredient | Biological Products | Disposable Import Drug Application | 2020-11-20 | Novo Nordisk A/S | Novo Nordisk A/S | Certificate Issued | 2020-12-17 | view |
| CXSS1400002 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2014-12-25 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2020-12-10 | view |
| JYSZ2000017 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | License Renew | 2020-11-23 | 丹麦诺和诺德公司 | Novo Nordisk A/S | In Review | 2020-11-21 | view |
| JYSZ2000016 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | License Renew | 2020-11-23 | 丹麦诺和诺德公司 | Novo Nordisk A/S | In Review | 2020-11-21 | view |
| JYSF2000025 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.1) | Supplementary Application | 2020-10-16 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2020-10-30 | view |
| JYSB2000459 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.1) | Supplementary Application | 2020-09-11 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2020-09-18 | view |
| CXSL2000249 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.3) | New Drug Application | 2020-08-27 | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | In Review | 2020-08-26 | view |
| JYSB2000365 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(1) | Supplementary Application | 2020-08-07 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2020-08-17 | view |
